|
July
5, 2005 |
|
|
|
|
|
IMAGING
• Aetna
Issues New Reimbursement Policy |
|
QUALITY
IMPROVEMENT
• AMA
Adopts Pay-for-Performance Guidelines
|
|
MEDICAL
LIABILITY REFORM
• Connecticut Governor Signals Willingness
to Sign Liability Law |
LEGISLATIVE/REGULATORY
• Medicare Pay-for-Performance Bill
Unveiled
• House Approves FY 2006 Labor-HHS
Appropriations Billg
• Drug Tracking Bill Moves Forward
• FDA Panel Rejects Artificial Heart
|
| IMAGING |
|
Aetna
Issues New Reimbursement Policy
As
of June 15, Aetna will reimburse each of the add-on
codes wall motion study (78478) and ejection fraction
(78480 ) when billed with a myocardial perfusion imaging
study (78460-78465). Aetna recently sent an update in
its provider newsletter explaining the new reimbursement
policy.
ACC
has confirmed with Susan Millerick and Stacie Watson,
Aetna’s spokesperson and Head of Clinical and
Reimbursement Policy Administration, respectively, that
the system change will allow reconsideration (retroactive
reimbursement) of claims, based on the May 14 implementation
date, for 180 days (six months) from the date of the
initial claim determination (Aetna’s date) provided
that the claim was submitted within the timely filing
limits, or 60 days for an appeal if reconsideration
has previously occurred, provided appeal rights still
exist for the claim. For more information, contact Mia
Thomas of Payer Advocacy at 301-581-3418. |
| QUALITY
IMPROVEMENT |
|
AMA
Adopts Pay-for-Performance Guidelines
The
American Medical Association (AMA) House of Delegates
has adopted comprehensive guidelines for pay-for-performance
programs. The guidelines
cover quality of care; the patient/physician relationship;
physician participation; physician data and reporting;
and program rewards. While the AMA has tried to forge
consensus among the physician community on a core set
of guidelines and principles, a number of surgical societies
concerned about the Congress’ interest in moving
to a pay-for-performance system as early as 2008 amended
the resolution so it states that the AMA oppose any
pay-for-performance programs unless they meet the guidelines
and principles. Some groups, including the ACC and the
American College of Physicians (ACP), are concerned
about the hard line that effectively has been drawn
by requiring that all the principles and guidelines
be met. “This is
going to make it very difficult for the AMA to engage
constructively in influencing what comes out of Medicare,”
said Robert Doherty, senior vice president of ACP. |
| MEDICAL
LIABILITY REFORM |
Connecticut
Governor Signals Willingness to Sign Liability Law
Connecticut
Gov. M. Jodi Rell, R, has said she is “inclined
to sign” a bill adopted by the state legislature
that would require the state insurance department to approve
malpractice insurance premium rates of
7.5 percent or higher. The measure also limits attorney
fees in malpractice cases and reduces interest rates on
malpractice settlements paid over time. |
| LEGISLATIVE/REGULATORY |
|
Medicare
Pay-for-Performance Bill Unveiled
Senate
Finance Committee Chairman Charles Grassley, R-IA, and
the committee’s ranking Democrat, Senator Max
Baucus, MT, have introduced a bill to encourage reporting
of quality data. The legislation would allow the secretary
of the Department of Health and Human Services (HHS)
to first reward providers when they report quality data
and then, again, when they achieve quality improvements.
The
bill would also authorize a national healthcare information
technology pilot program. The ACC is currently reviewing
the legislation. |
House
Approves FY 2006 Labor-HHS Appropriations Bill
The
House of Representatives voted 250-151 to pass the $602
billion Labor-Health and Human Services-Education appropriations
bill for fiscal year 2006. The measure, adopted June 24,
funds the Medicare and Medicaid programs and includes
monies to implement the new Medicare prescription drug
program. Funding for the National Institutes of Health
is slated at $28.5 billion, a half-percent increase from
the current year. Prior to passage, the House rejected
an amendment that would have prohibited the use of appropriated
funds for the distribution of personal Medicare and Medicaid
beneficiary information to private companies for marketing
purposes. A Senate subcommittee
will take up its version of the funding measure after
the July 4 congressional recess. |
Drug
Tracking Bill Moves Forward
The
House Energy and Commerce Subcommittee on Health has marked
up legislation (H.R. 1132) to provide grants to states
to establish a uniform electronic database system to enable
physicians and pharmacists to flag drug interactions.
The measure would also allow providers to track patients
who abuse prescription drugs. The Senate Health,
Education, Labor and Pensions Committee has approved similar
legislation. |
FDA
Panel Rejects Artificial Heart
A
Food and Drug Administration (FDA) advisory panel has
recommended, 7-6, that the agency reject a request by
Abiomed to sell the AbioCor artificial
heart. The panel found that most recipients of the fully
implantable artificial heart had suffered serious side
effects. |
| Questions?
Comments? Send your feedback to epubs@acc.org
and include the name of the publication in the subject
line. |